Maria S. Asdourian

813 total citations
16 papers, 537 citations indexed

About

Maria S. Asdourian is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Maria S. Asdourian has authored 16 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 4 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Maria S. Asdourian's work include Cancer Immunotherapy and Biomarkers (8 papers), Lymphatic System and Diseases (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Maria S. Asdourian is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Lymphatic System and Diseases (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Maria S. Asdourian collaborates with scholars based in United States, China and Israel. Maria S. Asdourian's co-authors include Cheryl L. Brunelle, Melissa N. Skolny, Alphonse G. Taghian, Laura Salama, Hoda E. Sayegh, Meyha N. Swaroop, Hui Zheng, Amir I. Mina, Steven T. Chen and Kerry L. Reynolds and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Lancet Oncology.

In The Last Decade

Maria S. Asdourian

15 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria S. Asdourian United States 8 358 165 135 102 71 16 537
Branavan Manoranjan Canada 18 235 0.7× 239 1.4× 133 1.0× 27 0.3× 389 5.5× 48 1.3k
Kiyoshi Onda Japan 16 93 0.3× 97 0.6× 71 0.5× 69 0.7× 186 2.6× 38 832
Wei‐Hsiu Liu Taiwan 15 211 0.6× 123 0.7× 209 1.5× 75 0.7× 350 4.9× 44 720
Frauke Forstreuter Germany 7 88 0.2× 84 0.5× 131 1.0× 29 0.3× 241 3.4× 7 511
Lingyi Huang China 11 401 1.1× 98 0.6× 179 1.3× 106 1.0× 427 6.0× 27 823
Takafumi Ide Japan 14 60 0.2× 120 0.7× 119 0.9× 42 0.4× 281 4.0× 33 797
Françoise Bruyére Belgium 10 271 0.8× 102 0.6× 67 0.5× 19 0.2× 198 2.8× 11 453
Clarissa Amaya United States 12 254 0.7× 96 0.6× 52 0.4× 21 0.2× 139 2.0× 18 542
Shunji Yunoue Japan 16 88 0.2× 124 0.8× 69 0.5× 35 0.3× 237 3.3× 26 733
Eliana Amato Italy 12 405 1.1× 201 1.2× 249 1.8× 89 0.9× 251 3.5× 14 716

Countries citing papers authored by Maria S. Asdourian

Since Specialization
Citations

This map shows the geographic impact of Maria S. Asdourian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria S. Asdourian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria S. Asdourian more than expected).

Fields of papers citing papers by Maria S. Asdourian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria S. Asdourian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria S. Asdourian. The network helps show where Maria S. Asdourian may publish in the future.

Co-authorship network of co-authors of Maria S. Asdourian

This figure shows the co-authorship network connecting the top 25 collaborators of Maria S. Asdourian. A scholar is included among the top collaborators of Maria S. Asdourian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria S. Asdourian. Maria S. Asdourian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Stephens, Michael, Maria S. Asdourian, Nishi Shah, et al.. (2023). Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma. Journal of the American Academy of Dermatology. 89(1). 140–142. 5 indexed citations
2.
Asdourian, Maria S., Nishi Shah, T. Otto, et al.. (2023). Noncutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy. Journal of the American Academy of Dermatology. 88(6). 1368–1370. 2 indexed citations
3.
Asdourian, Maria S., Yevgeniy R. Semenov, T. Otto, et al.. (2022). Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade. Journal of the American Academy of Dermatology. 88(2). 485–487. 4 indexed citations
4.
Asdourian, Maria S., Leah L. Thompson, T. Otto, et al.. (2022). Dermatology evaluation for cutaneous immune-related adverse events is associated with improved survival in cancer patients treated with checkpoint inhibition. Journal of the American Academy of Dermatology. 88(3). 711–714. 7 indexed citations
5.
Asdourian, Maria S., T. Otto, Leah L. Thompson, et al.. (2022). Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma. Journal of the American Academy of Dermatology. 87(5). 1147–1149. 5 indexed citations
6.
Asdourian, Maria S., Leah L. Thompson, T. Otto, et al.. (2022). Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A multicenter retrospective study. Journal of the American Academy of Dermatology. 88(2). 474–476.
7.
Asdourian, Maria S., Leah L. Thompson, T. Otto, et al.. (2022). Evaluating patterns of co-occurrence between cutaneous and noncutaneous immune-related adverse events after immune checkpoint inhibitor therapy. Journal of the American Academy of Dermatology. 88(1). 246–249. 2 indexed citations
8.
Asdourian, Maria S., et al.. (2022). Neutrophilic Dermatosis and Management Strategies for the Inpatient Dermatologist. Current Dermatology Reports. 11(3). 146–157. 2 indexed citations
9.
Asdourian, Maria S., et al.. (2022). Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer. JAMA Dermatology. 158(8). 933–933. 41 indexed citations
10.
McDuff, Susan G. R., Amir I. Mina, Cheryl L. Brunelle, et al.. (2018). Timing of Lymphedema After Treatment for Breast Cancer: When Are Patients Most At Risk?. International Journal of Radiation Oncology*Biology*Physics. 103(1). 62–70. 127 indexed citations
11.
Brunelle, Cheryl L., Meyha N. Swaroop, Melissa N. Skolny, et al.. (2018). Hand Edema in Patients at Risk of Breast Cancer–Related Lymphedema: Health Professionals Should Take Notice. Physical Therapy. 98(6). 510–517. 4 indexed citations
12.
Li, Yiqing, Lukas Andereggen, Kenya Yuki, et al.. (2017). Mobile zinc increases rapidly in the retina after optic nerve injury and regulates ganglion cell survival and optic nerve regeneration. Proceedings of the National Academy of Sciences. 114(2). E209–E218. 118 indexed citations
13.
Sayegh, Hoda E., Maria S. Asdourian, Meyha N. Swaroop, et al.. (2017). Diagnostic Methods, Risk Factors, Prevention, and Management of Breast Cancer-Related Lymphedema: Past, Present, and Future Directions. Current Breast Cancer Reports. 9(2). 111–121. 60 indexed citations
14.
Asdourian, Maria S., Meyha N. Swaroop, Hoda E. Sayegh, et al.. (2017). Association Between Precautionary Behaviors and Breast Cancer–Related Lymphedema in Patients Undergoing Bilateral Surgery. Journal of Clinical Oncology. 35(35). 3934–3941. 41 indexed citations
15.
16.
Skolny, Melissa N., et al.. (2016). A comprehensive review of bioimpedance spectroscopy as a diagnostic tool for the detection and measurement of breast cancer-related lymphedema. Journal of Surgical Oncology. 114(5). 537–542. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Branavan Manoranjan Breakdown of academic impact, for papers by Kiyoshi Onda Breakdown of academic impact, for papers by Wei‐Hsiu Liu Breakdown of academic impact, for papers by Frauke Forstreuter Breakdown of academic impact, for papers by Lingyi Huang Breakdown of academic impact, for papers by Takafumi Ide Breakdown of academic impact, for papers by Françoise Bruyére Breakdown of academic impact, for papers by Clarissa Amaya Breakdown of academic impact, for papers by Shunji Yunoue Breakdown of academic impact, for papers by Eliana Amato
Rankless by CCL
2026